Keyphrases
Wilms Tumor
73%
Tumor
61%
Organoids
59%
Tumor Organoids
50%
Organoid Models
38%
Rhabdomyosarcoma
33%
Pediatric Tumors
26%
Pediatric
20%
Vulnerability
19%
Renal Tumor
19%
Organoid Culture
18%
Rhabdoid Tumor
18%
Neuroblastoma
16%
Tumors in children
16%
Differentiation State
15%
Cancer Research
15%
Intermediate Risk
14%
Pediatric Cancer
14%
Netherlands
13%
Tumor-specific
13%
Molecular Characterization
13%
Single-cell Transcriptomics
13%
Paneth Cells
13%
Cell Formation
13%
Patient Journey
13%
Prognostic Factors
13%
Narrative Review
13%
Human Intestinal Organoids
13%
Interleukin-22 (IL-22)
13%
Tissue Organoids
13%
RNA Sequencing (RNA-seq)
13%
Liquid Biopsy
13%
Patient-derived Organoids
12%
Drug Screening
12%
Overall Survival
12%
Targeted Therapy
12%
Relapsed or Refractory
12%
Adult Kidney
11%
Chimeric Antigen Receptor T Cells (CAR-T)
11%
Colorectal Cancer
11%
Kidney Cancer
10%
Drug Sensitivity
10%
Stem Cells
10%
Kidney Tumor
10%
Renal Cell Carcinoma
10%
Tumor Cells
10%
Patient-specific
10%
In Cancer
9%
Human Kidney
9%
Distant Metastasis
9%
Pediatric Radiology
9%
Colon Cancer
9%
Tumor Tissue
8%
Somatic mutation
8%
Event-free Survival
8%
Colorectal Cancer Progression
8%
Molecular Features
8%
Human Tissue
8%
Congenital Mesoblastic Nephroma
8%
Tumor Evolution
8%
Treatment Regimen
8%
Tumor-immune System
8%
Tumor Progression
8%
Cell Identity
8%
DNA Adduct Formation
8%
Immune Cells
8%
Tumor-derived Organoids
7%
Mesenchymal Tumor
7%
Transcription Factor
7%
Healthy Tissue
7%
Patient-derived
7%
Cell State
7%
Disease Modeling
7%
Clinical Practice
7%
Single-cell RNA Sequencing (scRNA-seq)
7%
Normal Kidney
7%
Neurofibromatosis Type 1 (NF-1)
7%
Epigenetic Modification
7%
Tubuloid
7%
Nephrogenic Rest
7%
Therapeutic Target
7%
Whole Genome Sequencing
7%
Clinical Trials
7%
MUTYH
7%
Whole Exome Sequencing
7%
Precision Oncology
7%
Soft Tissue Sarcoma
7%
Children with Cancer
7%
Kidney
7%
Epigenetics
7%
Tumorigenesis
7%
Cell of Origin
7%
Cancer Organoids
7%
Copy number Variation
6%
Driver mutations
6%
Neurofibromatosis Type I
6%
Atypical Teratoid
6%
Morphological Spectrum
6%
EGFR Kinase Domain
6%
Drug Screening Platform
6%
Medicine and Dentistry
Neoplasm
100%
Organoid
96%
Wilms' Tumor
68%
Pediatrics
52%
Rhabdomyosarcoma
37%
Kidney Tumour
33%
Malignant Neoplasm
23%
Pediatric Cancer
19%
Drug Screening
18%
Disease
16%
Solid Malignant Neoplasm
15%
Malignant Rhabdoid Tumour
15%
RNA Sequence
14%
Specific Tumor
14%
Childhood Cancer
13%
In Vitro
13%
Immunotherapy
13%
Liquid Biopsy
13%
Colorectal Carcinoma
13%
Morphology
12%
Prognostic Factor
12%
Cell Differentiation
12%
Somatics
11%
Overall Survival
11%
Cancer Research
10%
Adolescence
10%
Oncology
10%
Ganglioneuroblastoma
10%
Immunocompetent Cell
10%
Stem Cell
10%
Nephron
9%
Transcriptomics
9%
Paediatric Radiology
9%
Drug Sensitivity
9%
Kidney Cancer
9%
Diagnosis
8%
Messenger RNA
8%
Somatic Mutation
8%
Clear Cell Renal Cell Carcinoma
8%
Cancer Growth
8%
Whole Genome Sequencing
8%
Transcriptome
8%
Xenograft
8%
Personalized Medicine
7%
Prevalence
7%
Mesoblastic Nephroma
7%
Event Free Survival
7%
Transcription Factors
7%
Clustered Regularly Interspaced Short Palindromic Repeat
7%
Immunity
7%
Tumor Progression
7%
Precursor
7%
Soft Tissue Sarcoma
7%
Clinical Trial
6%
Fibrosarcoma
6%
Paneth Cell
6%
Tumor Microenvironment
6%
Malignant Peripheral Nerve Sheath Tumor
6%
Tumor Recurrence
6%
Neddylation
6%
Cancer Staging
6%
Systematic Review
6%
Vincristine
6%
Dactinomycin
6%
Pleiotropy
6%
Atypical Teratoid Rhabdoid Tumor
6%
Chimeric Antigen Receptor
6%
Primary Tumor
6%
Interleukin 22
6%
Progenitor Cell
6%
Gene Fusion
6%
Disease Predisposition
6%
Cancer Cell
6%
Phosphotransferase
6%
Adenoma
6%
Epidermal Growth Factor Receptor
6%
Hepatoblastoma
6%
Repressor Gene
6%
Enteroendocrine Cell
6%
Immunosuppressive Treatment
6%
Pontine Glioma
6%
Cancer Cell Culture
6%
Exome Sequencing
6%
Biological Marker
6%
Ex Vivo
6%
Neurofibromatosis Type I
6%
Kidney Tissue
5%
3D Imaging
5%
Etoposide
5%
Carboplatin
5%
Germ Cell
5%
Gene Expression
5%
Colon
5%
Tumor Cell
5%